| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | FORM S-8 REGISTRATION STATEMENT |
| 10 Nov 2026 | FORM 10-Q QUARTERLY REPORT FOR 09-30-2026 |
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA |
| 01 Oct 2026 |
Form 4: Manko Joseph M. Jr., Director and 3 others
Received 5,119 shares as a grant or award |
| 01 Oct 2026 |
Form 4: Cascella Robert, Director
Received 5,119 shares as a grant or award ($15K) |
| 01 Oct 2026 |
Form 4: Matin Shahriar, Director
Received 5,119 shares as a grant or award ($15K) |
| 01 Oct 2026 |
Form 4: Fletcher R John, Director
Received 7,679 shares as a grant or award ($22.5K) |
| 01 Oct 2026 |
Form 4: Wholihan Edward, Director
Received 5,119 shares as a grant or award ($15K) |
| 01 Oct 2026 |
Form 4: French Donna, Director
Received 5,119 shares as a grant or award ($15K) |
| 09 Sep 2026 |
Form 4: Kalbermatten Adam R, Chief Commercial Officer
Bought 32,000 shares ($101K) |
| 14 Aug 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
This Amendment No. 1 (this “Amendment”) to the Amended and Restated By-laws of KORU Medical Systems, Inc. effective February 5, 2026 (the “By-laws”) is made as of August 13, 2026 in accordance with Section 8.02 of the By-laws. Capitalize... |
| 06 Aug 2026 |
Form 4: Kalbermatten Adam R, Chief Commercial Officer
Received 75,000 shares by exercise or conversion · Gave up 25,483 shares to cover exercise price or tax ($109K) |
| 05 Aug 2026 | FORM 10-Q QUARTERLY REPORT FOR 06-30-2026 |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
MAHWAH, NJ – August 5, 2026 – KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-ce... |
| 03 Aug 2026 | 144 |
| 29 Jul 2026 | SCHEDULE 13G |
| 13 Jul 2026 |
Form 4/A: Kalbermatten Adam R, President and CEO
Granted 284,091 Performance Stock Unit |
| 02 Jul 2026 |
Form 4: Kalbermatten Adam R, President and CEO
Granted 286,697 Performance Stock Unit |
Loading...